Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900...
from NDTV Profit - Latest https://ift.tt/2NMLAB0
from NDTV Profit - Latest https://ift.tt/2NMLAB0
Aurobindo Pharma Shares Jump Over 6% After $900-Million US Acquisition
Reviewed by placements page
on
September 05, 2018
Rating:

No comments: